Literature DB >> 19246033

A similarity in the O-acetylation pattern of the O-antigens of Shigellaflexneri types 1a, 1b, and 2a.

Andrei V Perepelov1, Vyacheslav L L'vov, Bin Liu, Sof'ya N Senchenkova, Mariya E Shekht, Alexander S Shashkov, Lu Feng, Petr G Aparin, Lei Wang, Yuriy A Knirel.   

Abstract

Shigella flexneri type 2a is the first, and type 1b is the second, most prevalent isolates from patients with shigellosis in Russia. The O-specific polysaccharides (OPSs, O-antigens) of S. flexneri types 1-5 possess a common -->2)-alpha-l-RhapIII-(1-->2)-alpha-l-RhapII-(1-->3)-alpha-l-RhapI-(1-->3)-beta-d-GlcpNAc-(1--> backbone and differ from each other in its glucosylation or/and O-acetylation at various positions, the modifications being responsible for various O-factors. It was suggested that O-factor 6 expressed by type 1b is associated with O-acetylation of RhaI at position 2 but more than one O-acetyl group has been detected in the type 1b OPS [Kenne, L. et al. Eur. J. Biochem.1978, 91, 279-284]. In this work, O-acetylation of RhapI in the type 1b OPS was confirmed by NMR spectroscopy and location of an additional O-acetyl group at position either 3 (major) or 4 (minor) of RhapIII was determined. Type 1a differs from type 1b in the lack of O-acetylation of RhapI only. In type 2a, in addition to two reported major O-acetyl groups at position 6 of GlcNAc and position 3 of RhapIII [Kubler-Kielb, J. et al. Carbohydr. Res.2007, 342, 643-647], a minor O-acetyl group was found at position 4 of RhaIII. Therefore, RhapIII is O-acetylated in the same manner in all three S. flexneri serotypes studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246033     DOI: 10.1016/j.carres.2009.01.004

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  12 in total

1.  Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Authors:  Vladimir A Ledov; Marina E Golovina; Anna A Markina; Yuriy A Knirel; Vyacheslav L L'vov; Alexander L Kovalchuk; Petr G Aparin
Journal:  Vaccine       Date:  2019-01-19       Impact factor: 3.641

2.  Identification of an O-acyltransferase gene (oacB) that mediates 3- and 4-O-acetylation of rhamnose III in Shigella flexneri O antigens.

Authors:  Jianping Wang; Yuriy A Knirel; Ruiting Lan; Sof'ya N Senchenkova; Xia Luo; Andrei V Perepelov; Yiting Wang; Alexander S Shashkov; Jianguo Xu; Qiangzheng Sun
Journal:  J Bacteriol       Date:  2014-02-07       Impact factor: 3.490

3.  Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Christopher Mocca; Vince Pozsgay; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Carbohydr Res       Date:  2010-05-15       Impact factor: 2.104

4.  Serotype-converting bacteriophage SfII encodes an acyltransferase protein that mediates 6-O-acetylation of GlcNAc in Shigella flexneri O-antigens, conferring on the host a novel O-antigen epitope.

Authors:  Qiangzheng Sun; Yuriy A Knirel; Jianping Wang; Xia Luo; Sofya N Senchenkova; Ruiting Lan; Alexander S Shashkov; Jianguo Xu
Journal:  J Bacteriol       Date:  2014-08-11       Impact factor: 3.490

5.  Serological identification and prevalence of a novel O-antigen epitope linked to 3- and 4-O-acetylated rhamnose III of lipopolysaccharide in Shigella flexneri.

Authors:  Jianping Wang; Ruiting Lan; Yuriy A Knirel; Xia Luo; Sof'ya N Senchenkova; Alexander S Shashkov; Jianguo Xu; Qiangzheng Sun
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

6.  Influence of Shigella flexneri 2a O Antigen Acetylation on Its Bacteriophage Sf6 Receptor Activity and Bacterial Interaction with Human Cells.

Authors:  Min Yan Teh; Axel Furevi; Göran Widmalm; Renato Morona
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

7.  Topological characterisation and identification of critical domains within glucosyltransferase IV (GtrIV) of Shigella flexneri.

Authors:  Anesh Nair; Haralambos Korres; Naresh K Verma
Journal:  BMC Biochem       Date:  2011-12-22       Impact factor: 4.059

8.  Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate.

Authors:  Neil Ravenscroft; Martin Braun; Joerg Schneider; Anita M Dreyer; Michael Wetter; Micha A Haeuptle; Stefan Kemmler; Michael Steffen; Dominique Sirena; Stefan Herwig; Paula Carranza; Claire Jones; Andrew J Pollard; Michael Wacker; Michael Kowarik
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

9.  Structural and immunochemical studies of the lipopolysaccharide from the fish pathogen, Aeromonas bestiarum strain K296, serotype O18.

Authors:  Anna Turska-Szewczuk; Buko Lindner; Iwona Komaniecka; Alicja Kozinska; Agnieszka Pekala; Adam Choma; Otto Holst
Journal:  Mar Drugs       Date:  2013-04-17       Impact factor: 5.118

10.  Serotype-conversion in Shigella flexneri: identification of a novel bacteriophage, Sf101, from a serotype 7a strain.

Authors:  Richa Jakhetia; Aruna Marri; Jonas Ståhle; Göran Widmalm; Naresh K Verma
Journal:  BMC Genomics       Date:  2014-08-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.